Is antimicrobial resistance evolution accelerating?
23 October 2020
The problem of drug resistance evolution has been observed early on in the antibiotic era. Ultimately, however, the introduction of each antimicrobial resulted in resistance evolution in target and nontarget microbes. In realization of this problem, some antibiotics such as daptomycin were even developed with avoiding resistance evolution in mind, yet it took only 2 years from the introduction of daptomycin until resistance was recorded. But how fast is resistance evolving?
Further reading: PLOS Pathogens
Author(s): Christopher Witzany, Sebastian Bonhoeffer, Jens Rolff
Effective Surveillance
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.